OpAns, LLC   Report issue

For profit Phase 1
Founded: Durham NC United States (2004)

Organization Overview

First Clinical Trial
2012
NCT01491919
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now